LATTITUDE INDUCTIVE COMMUNICATOR
FDA premarket approval P910077/S092 · decided 2009-04-28
Approval details
- PMA number
- P910077
- Supplement
- S092
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- LATTITUDE INDUCTIVE COMMUNICATOR
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2009-03-04
- Decision date
- 2009-04-28
- Days to decision
- 55 days
- Decision code
- APPR
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- APPROVAL FOR SOFTWARE CHANGES TO THE LATITUDE PATIENT MANAGEMENT SYSTEM INDUCTIVE COMMUNICATOR MODEL 6481, VERSION 1.5.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.